Abstract

Excessive mitochondrial fission acts as a pro-proliferative marker in some cancers and organ fibrosis; its potential role in renal fibroblast activation and fibrogenesis has never been investigated. Here, we showed more pronounced fragmented mitochondria in fibrotic than in non-fibrotic renal fibroblast in humans and mice. In a mouse model of obstructive nephropathy, phosphorylation of Drp1 at serine 616 (p-Drp1S616) and acetylation of H3K27(H3K27ac) was increased in fibrotic kidneys; pharmacological inhibition of mitochondrial fission by mdivi-1 substantially reduced H3K27ac levels, fibroblasts accumulation, and interstitial fibrosis. Moreover, mdivi-1 treatment was able to attenuate the established renal fibrosis. In cultured renal interstitial fibroblasts, targeting Drp1 using pharmacological inhibitor or siRNA suppressed TGF-β1-elicited cell activation and proliferation, as evidenced by inhibiting expression of α-smooth muscle actin (α-SMA) and collagen I, as well as by reducing DNA synthesis. In contrast, Drp1 deletion enhanced cell apoptosis, along with decreased mitochondrial fragmentation, mtROS elevation, and glycolytic shift upon TGF-β1 stimulation. In Drp1 deletion fibroblasts, re-expression of wild-type Drp1 rather than Drp1S616A mutant restores the reduction of TGF-β-induced-Drp1 phosphorylation, H3K27ac, and cell activation. Moreover, TGF-β1 treatment increased the enrichment of H3K27ac at the promoters of α-SMA and PCNA, which was reversed in Drp1-knockdown fibroblasts co-transfected with empty vector or Drp1S616A, but not wild-type Drp1. Collectively, our results imply that inhibiting p-Drp1S616-mediated mitochondrial fission attenuates fibroblast activation and proliferation in renal fibrosis through epigenetic regulation of fibrosis-related genes transcription and may serve as a therapeutic target for retarding progression of chronic kidney disease.

Highlights

  • In response to various chronic insults, renal interstitial resident fibroblasts undergo morphological and functional alteration to transdifferentiate into myofibroblasts, which express α-smooth muscle actin (α-SMA) and produce abundance of extracellular matrix components[1,2]

  • These results indicate that impaired mitochondrial dynamics in fibroblasts may be involved in the pathogenesis of renal fibrosis

  • Immunofluorescence staining results showed that the expression of α-SMA was barely expressed and p-Drp1S616 was not detectable in shamoperated kidneys, whereas increased expression of p-Drp1S616 and α-SMA positive myofibroblasts accumulation was observed in ureteral obstruction (UUO)-induced fibrotic kidneys (Fig. 1g)

Read more

Summary

Introduction

In response to various chronic insults, renal interstitial resident fibroblasts undergo morphological and functional alteration to transdifferentiate into myofibroblasts, which express α-SMA and produce abundance of extracellular matrix components[1,2]. The mechanisms underlying the Mitochondria are extremely dynamic organelles, constantly undergoing antagonistic processes of fission and fusion. Mitofusin-1 (Mfn1), Mitofusin-2 (Mfn2), and optic atrophy 1 (OPA1) proteins mediate fusion, whereas dynamin-related protein 1 (Drp1) executes fission by recruiting to the mitochondrial outer membrane to drive scission[5,6,7]. Phosphorylation of Drp[1] at serine 616 (p-Drp1S616) promotes Drp[1] activity. Phosphorylation of serine 637 (p-Drp1S637) represses its activity and leads to mitochondrial elongation[5].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call